Hims & Hers Health Appoints New Director, Amends Compensation

Ticker: HIMS · Form: 8-K/A · Filed: 2024-06-06T00:00:00.000Z

Sentiment: neutral

Topics: director-change, executive-compensation, amendment

Related Tickers: HIMS

TL;DR

Hims & Hers swapped a director and tweaked exec pay, filing an amendment on 4/24.

AI Summary

Hims & Hers Health, Inc. filed an 8-K/A on April 24, 2024, to amend a previous filing. The amendment concerns the departure of director Dr. Andrew Lee, effective April 24, 2024, and the appointment of Dr. Jessica Wu as a new director. The company also announced changes to its executive compensation arrangements.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Changes in board composition and executive compensation can sometimes indicate underlying issues or strategic shifts that warrant closer investor scrutiny.

Key Players & Entities

FAQ

Who is the departing director of Hims & Hers Health, Inc.?

Dr. Andrew Lee is the departing director.

When was the departure of Dr. Andrew Lee effective?

The departure of Dr. Andrew Lee was effective April 24, 2024.

Who has been appointed as a new director for Hims & Hers Health, Inc.?

Dr. Jessica Wu has been appointed as a new director.

What type of filing is this for Hims & Hers Health, Inc.?

This is a Form 8-K/A, an amendment to a previous filing.

What other items are addressed in this amendment besides director changes?

The amendment also addresses changes to compensatory arrangements of certain officers.

From the Filing

0001773751-24-000164.txt : 20240606 0001773751-24-000164.hdr.sgml : 20240606 20240606163031 ACCESSION NUMBER: 0001773751-24-000164 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240424 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240606 DATE AS OF CHANGE: 20240606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hims & Hers Health, Inc. CENTRAL INDEX KEY: 0001773751 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38986 FILM NUMBER: 241025899 BUSINESS ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 BUSINESS PHONE: 415-851-0195 MAIL ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 FORMER COMPANY: FORMER CONFORMED NAME: Oaktree Acquisition Corp. DATE OF NAME CHANGE: 20190412 8-K/A 1 hims-20240424.htm 8-K/A hims-20240424 0001773751 false 0001773751 2024-03-30 2024-03-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________________________________________________________________________________ FORM  8-K/A _____________________________________________________________________________________________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2024 _____________________________________________________________________________________________________________________ HIMS & HERS HEALTH, INC. (Exact name of registrant as specified in its charter) _____________________________________________________________________________________________________________________ Delaware   001-38986   98-1482650 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) 2269 Chestnut Street, #523 San Francisco , CA 94123 (Address of principal executive offices) ( 415 ) 851-0195 (Registrant’s telephone number, including area code) ______________________________________________________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading symbol Name of each exchange on which registered Class A Common Stock, $0.0001 par value   HIMS   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).  Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐ Item 5.02 Departu

View on Read The Filing